Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
A Satisfied customer is worth ten times more than what you write or say about yourself.
Klaus joined Tecan in June 2013 as EVP Corporate Development and a member of the Management Board of the Tecan Group. In February 2017, he took over the role as EVP Life Sciences Business leading all of Tecan’s end-user business division. Before joining Tecan, Klaus Lun was Vice President Global Product Marketing at Molecular Devices Inc., a company belonging to the Danaher Group, with responsibility for strategy development, positioning and marketing for the entire product portfolio. Prior to this, he was responsible for running the Drug Discovery and Bioresearch business as Vice President Drug Discovery and Bioresearch. Klaus Lun was Director Business Development from 2007 to 2011 at Danaher Group, for the operating company Leica Microsystems, where he was responsible for corporate mergers, takeovers and licensing. He was also closely involved in a number of transactions entered into by the parent company Danaher. Klaus Lun studied biology at the University of Bayreuth and Tübingen (Germany) and gained his doctorate in neurobiology at the University of Heidelberg (Germany). He also has an MBA from the University of Mannheim (Germany). |
Since 2017 |
Executive Vice President, Head of Life Sciences Business, Tecan Group |
2013 – 2017 |
Executive Vice President, Head of Corporate Development, Tecan Group |
2011 – 2013 |
Vice President Drug Discovery and Bioresearch and Vice President Global Product Marketing with responsibility for strategy development, positioning and marketing for the entire product portfolio at Molecular Devices Inc., a company belonging to the Danaher Group. |
2007 – 2011 |
Director Business Development at Leica Microsystems, also part of the Danaher Group. Responsibility for corporate mergers, takeovers and licensing. |
2002 – 2007 |
Variety of positions at Amaxa GmbH, now part of the Lonza Group, most recently as a Senior Project Manager with responsibility, among other things, for the development and rollout onto the market of a variety of clinical products. |
CrestOptics2, Non Executive Director, Member of the Board of Directors 2 private company |